The combination of ICB with CAR-T leads to express the CCR2 receptor (to enhance homing to the tumor), IL12 (to enhance cytolytic activity and T cell survival), and IL7 (to enhance memory differentiation) (Ren et al., 2017[100]). This evidence concerns the gene IL7 and neoplasm.